Here's the live share price of Mankind Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Mankind Pharma | 1.82 | 14.17 | 22.51 | 11.76 | -1.04 | 23.48 | 11.97 |
| Sun Pharmaceutical Industries | 1.17 | 13.20 | 8.82 | 5.91 | 8.86 | 26.25 | 22.25 |
| Divi's Laboratories | -0.95 | 9.08 | 8.92 | 7.56 | 4.66 | 28.05 | 10.94 |
| Torrent Pharmaceuticals | 1.47 | 8.23 | 3.77 | 21.26 | 36.06 | 38.90 | 26.92 |
| Cipla | -2.83 | 13.39 | 5.42 | -7.50 | -5.67 | 14.76 | 8.57 |
| Dr. Reddy's Laboratories | 1.24 | 8.05 | 0.92 | 5.98 | 7.70 | 13.96 | 4.80 |
| Lupin | 1.30 | -1.06 | 1.88 | 12.74 | 14.61 | 43.43 | 13.49 |
| Zydus Lifesciences | 4.53 | 11.56 | 14.13 | 12.08 | 16.46 | 26.96 | 11.08 |
| Aurobindo Pharma | 2.44 | 11.16 | 34.47 | 28.30 | 28.45 | 36.89 | 8.82 |
| Laurus Labs | 2.62 | 21.13 | 32.74 | 38.10 | 126.11 | 62.97 | 22.55 |
| Biocon | 2.84 | 19.27 | 11.15 | 8.74 | 26.50 | 21.53 | 2.42 |
| Glenmark Pharmaceuticals | 1.91 | 6.81 | 17.03 | 29.26 | 65.65 | 57.95 | 31.46 |
| Alkem Laboratories | -1.44 | -3.50 | 0.12 | -3.55 | 2.26 | 19.10 | 12.87 |
| Abbott India | 0.89 | 9.32 | 4.84 | -6.08 | -11.65 | 9.12 | 11.57 |
| Anthem Biosciences | -6.46 | 3.68 | 10.02 | 20.55 | 4.83 | 1.58 | 0.95 |
| Ipca Laboratories | 4.70 | 12.17 | 12.19 | 14.76 | 12.69 | 34.39 | 8.28 |
| Ajanta Pharma | -3.41 | 12.70 | 5.81 | 26.79 | 19.41 | 33.88 | 19.58 |
| GlaxoSmithKline Pharmaceuticals | -4.29 | -4.65 | -12.26 | -7.32 | -22.46 | 21.23 | 9.61 |
| Gland Pharma | 23.58 | 31.41 | 29.94 | 29.54 | 48.93 | 37.88 | -5.91 |
| J B Chemicals & Pharmaceuticals | 1.87 | 9.28 | 6.38 | 26.12 | 30.34 | 30.69 | 24.69 |
Source: Dion Global
Over the last one year, Mankind Pharma has declined 1.04% compared to peers like Sun Pharmaceutical Industries (8.86%), Divi's Laboratories (4.66%), Torrent Pharmaceuticals (36.06%). From a 5 year perspective, Mankind Pharma has underperformed peers relative to Sun Pharmaceutical Industries (22.25%) and Divi's Laboratories (10.94%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,472.73 | 2,510.14 |
| 10 | 2,437.48 | 2,459.24 |
| 20 | 2,349.14 | 2,378.4 |
| 50 | 2,192.68 | 2,261.98 |
| 100 | 2,168.44 | 2,230.35 |
| 200 | 2,292.96 | 2,266.44 |
Source: Dion Global
In the latest quarter, Mankind Pharma remained same as its previous close in promoter holding, while DII stake increased to 14.46%, FII holding fell to 10.24%, and public shareholding moved down to 2.63% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 40,72,930 | 1.71 | 915.07 | |
| 27,39,492 | 1.61 | 615.48 | |
| 22,99,994 | 1.13 | 516.74 | |
| 22,48,970 | 7.58 | 505.28 | |
| 17,61,039 | 0.77 | 395.65 | |
| 16,64,835 | 1.46 | 374.04 | |
| 13,93,048 | 0.99 | 312.98 | |
| 13,28,039 | 0.63 | 298.37 | |
| 12,31,676 | 3.24 | 276.72 | |
| 11,31,195 | 3.04 | 254.15 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| May 21, 2026, 02:46 AM IST IST | Mankind Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| May 20, 2026, 09:37 PM IST IST | Mankind Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome |
| May 20, 2026, 01:36 AM IST IST | Mankind Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| May 20, 2026, 01:30 AM IST IST | Mankind Pharma - Announcement under Regulation 30 (LODR)-Investor Presentation |
| May 20, 2026, 01:06 AM IST IST | Mankind Pharma - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
Source: Dion Global
Mankind Pharma Ltd. is a Public Limited Listed company incorporated on 03/07/1991 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1991PLC044843 and registration number is 044843. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company's Total Operating Revenue is Rs. 10421.18 Cr. and Equity Capital is Rs. 41.28 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Mankind Pharma is ₹2,506.70 as on May 21, 2026.
The Mankind Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Mankind Pharma is ₹103,503.95 Cr as on May 21, 2026.
Today’s highest and lowest price of Mankind Pharma are ₹2,640.00 and ₹2,497.00.
The 52-week high/low is the highest and lowest price at which Mankind Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Mankind Pharma is ₹2,726.75 and 52-week low of Mankind Pharma is ₹1,909.90 as on May 21, 2026.
The Mankind Pharma has shown returns of -2.97% over the past day, 14.17% for the past month, 22.51% over 3 months, -1.04% over 1 year, 23.48% across 3 years, and 11.97% over 5 years.
P/E ratio of and PB ratio of Mankind Pharma are 54.11 and 6.59 on May 21, 2026. While the company gives a dividend yield of 0.04 per annum.
Source: Dion Global